Montreal Cognitive Assessment (MoCA)

This article or area is currently under construction and may only be partially complete. Please come back soon to see the finished work! (29/03/2022)

Objective[edit | edit source]

It was developed by Dr. Ziad S. Nasreddine and colleagues for quickly screening individuals for mild cognitive impairment.[1]

Intended Population[edit | edit source]

It can be used on the following populations:

  • Older adults[2]
  • Alzheimer's dementia[3]
  • Vascular cognitive impairment
  • Stroke
  • Parkinson's disease
  • Huntington's disease
  • Schizophrenia

Method of Use[edit | edit source]

Reference[edit | edit source]

Evidence[edit | edit source]

Reliability[edit | edit source]

Validity[edit | edit source]

Responsiveness[edit | edit source]

Miscellaneous[edit | edit source]

Links[edit | edit source]

References[edit | edit source]

  1. Nasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005 Apr;53(4):695-9.
  2. Feeney J, Savva GM, O'Regan C, King-Kallimanis B, Cronin H, Kenny RA. Measurement Error, Reliability, and Minimum Detectable Change in the Mini-Mental State Examination, Montreal Cognitive Assessment, and Color Trails Test among Community Living Middle-Aged and Older Adults. J Alzheimers Dis. 2016 May 31;53(3):1107-14.
  3. Lam B, Middleton LE, Masellis M, Stuss DT, Harry RD, Kiss A, Black SE. Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing. J Am Geriatr Soc. 2013 Dec;61(12):2181-5.